Market Place
Sourcing Support
All News #Library
Biotech
Zelluna ASA [ZLNA]: Annual Report 2025
25 Mar 2026 //
GLOBENEWSWIRE
Zelluna Partners with Etcembly for AI-Enabled TCR Engineering
09 Mar 2026 //
GLOBENEWSWIRE
Zelluna Approved For First Human Trial Of TCR-NK Cancer Therapy
24 Feb 2026 //
INDPHARMAPOST
Zelluna ASA: Achieves Key Milestone With Q4 2025 CTA Submission
12 Feb 2026 //
GLOBENEWSWIRE
Zelluna Selects Medpace as CRO for ZIMA-101 First-in-Human Trial
11 Feb 2026 //
GLOBENEWSWIRE
Zelluna ASA: To Host Q4 2025 Results Webcast
05 Feb 2026 //
GLOBENEWSWIRE
Zelluna Promotes Emilie Gauthy To Chief Technology Officer
03 Feb 2026 //
GLOBENEWSWIRE
Zelluna Submits UK CTA for ZIMA-101 First-in-Human Trial
17 Dec 2025 //
GLOBENEWSWIRE
Zelluna Finishes Initial GMP Batch Of ZI-MA4-1, TCR-NK Cell Trial
12 Dec 2025 //
GLOBENEWSWIRE
Zelluna Gets MHRA Nod, Advances UK Trial Plan for ZI-MA4-1
09 Oct 2025 //
GLOBENEWSWIRE
Zelluna ASA`s Q2 2025 Financial Results and Business Update
20 Aug 2025 //
GLOBENEWSWIRE
Zelluna ASA [ZLNA]: Reverse share split and ISIN change details
27 Mar 2025 //
GLOBENEWSWIRE
Zelluna ASA Becomes First Cell Therapy Firm Listed In Oslo
03 Mar 2025 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.